During the past decade, Ewha womans university mokdong hospital conducted 70 clinical trials. In the 10-year time frame, 70 clinical trials started and 16 clinical trials were completed, i.e. on average, 22.9% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 12 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ewha womans university mokdong hospital" #1 sponsor was "Ewha Womans University" with 12 trials, followed by "Celgene" with 11 trials sponsored, "Ewha Womans University Mokdong Hospital" with 11 trials sponsored, "Hoffmann-La Roche" with 10 trials sponsored and "Pfizer" with 10 trials sponsored. Other sponsors include 60 different institutions and companies that sponsored additional 46 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ewha womans university mokdong hospital" #1 collaborator was "Asan Medical Center" with 4 trials as a collaborator, "Chonnam National University Hospital" with 4 trials as a collaborator, "Ewha Womans University Mokdong Hospital" with 4 trials as a collaborator, "Hallym University Medical Center" with 4 trials as a collaborator and "Severance Hospital" with 4 trials as a collaborator. Other collaborators include 83 different institutions and companies that were collaborators in the rest 70 trials.

According to Clinical.Site data, the most researched conditions in "Ewha womans university mokdong hospital" are "Osteoarthritis" (14 trials), "Breast Cancer" (9 trials), "Crohn Disease" (6 trials), "Ulcerative Colitis" (4 trials) and "Essential Hypertension" (3 trials). Many other conditions were trialed in "Ewha womans university mokdong hospital" in a lesser frequency.

Most popular intervention types in "Ewha womans university mokdong hospital" are "Drug" (74 trials), "Device" (20 trials), "Biological" (11 trials), "Other" (9 trials) and "Procedure" (9 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (19 trials), "Ozanimod" (4 trials), "Abemaciclib" (2 trials), "Amlodipine 10mg, Candesartan cilexetil 16mg" (2 trials) and "Amlodipine 5mg" (2 trials). Other intervention names were less common.

The vast majority of trials in "Ewha womans university mokdong hospital" are 105 trials for "All" genders, 11 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Ewha womans university mokdong hospital". 1 are not yet recruiting, 11 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 62 completed trials in Ewha womans university mokdong hospital, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Ewha womans university mokdong hospital, 2 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 45 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 22 trials, and there were also 9 trials that are defined as “Not Applicable".

Ewha womans university mokdong hospital has several departments that took part in Clinical trials: "Ewha Womans University Mokdong Hospital; Dept of Neurology" - 2 trials